Condition: Heart Failure · Cognitive Impairment · Carotid Stenosis · Sponsor: John Paul II Hospital, Krakow
TRACE-IMPAIR is a prospective, clinical study of consecutive patients that evaluates the relationship between heart failure (HF) and cognitive impairment in relation to carotid and cerebral flow. The carotid and cerebral flow will be assessed using Doppler ultrasonography, and cognitive function will be estimated during routine neuropsychological tests. It is an observational, three(natural)-group, single-center study. It is also an Academic Registry - the scientific activity of the Faculty of Medicine, Collegium Medicum, Jagiellonian University, and John Paul II Hospital.
This description comes directly from the study's public registry record.
Piotr Musialek, MD, DPhil · +48126142287 · pmusialek@szpitaljp2.krakow.pl
Karolina Dzierwa, MD, PhD · +48126143158 · kdzierwa@szpitaljp2.krakow.pl
Always discuss trial participation with your own doctor first.
| Department of Cardiac and Vascular Diseases, The John Paul II Hospital | Krakow, MP, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05250349